SLC22A17 and B-cell chronic lymphocytic leukemia: As exemplified in Figure 4A, a lethal effect was observed for NGAL-R+ CLL cells after their incubation with the anti-NGAL-R antibodies compared with control (IgG) experiments (i.e., annexin V+ cells).